Introduction {#s1}
============

*Staphylococcus aureus* is an opportunistic pathogen sometimes associated with serious skin and soft tissue infections in humans and animals ([@bib30]). *S. aureus* encodes a large number of virulence factors that allow it to adapt to a variety of niches and to evade both the innate and adaptive immune system ([@bib2]). The emergence of *S. aureus* strains that are resistant to most antibiotics in common use has become a significant public health concern ([@bib16]; [@bib14]).

Most virulence factors in *S. aureus* are encoded on mobile genetic elements (MGEs) like bacteriophages, plasmids and genomic islands ([@bib29]). *S. aureus* pathogenicity islands (SaPIs) are a family of genomic islands that encode a range of virulence factors, including toxins, adhesins, coagulation factors and immunomodulatory factors ([@bib17]; [@bib34]; [@bib44]; [@bib35]). Many SaPIs encode superantigen toxins, which hyperactivate the immune system by bypassing the normal antigen presentation mechanism ([@bib1]). For example, SaPI1, SaPI2 and SaPIbov1 carry the *tst* gene, which encodes the toxic shock syndrome toxin (TSST-1) that is the causative agent of toxic shock, a frequently fatal condition ([@bib26]). SaPI1 also includes *sel* and *seq*, encoding staphylococcal enterotoxins L and Q, respectively ([@bib28]).

Transduction by phages is the main mode of horizontal transmission of MGEs in *S. aureus*. SaPIs engage in a kind of 'molecular piracy', in which they co-opt the structural proteins of a 'helper' bacteriophage for their own genome encapsidation and high-frequency transfer ([@bib10]). This arrangement differs from typical satellite viruses, which encode their own structural proteins, but depend on other viruses for other functions, and is far more efficient than generalized transduction. Bacteriophage 80α is a temperate siphovirus that can act as helper for several SaPIs, including SaPI1, SaPI2 and SaPIbov1 ([@bib9]). 80α has a 63 nm diameter *T* = 7 icosahedral capsid and a 190 nm long, flexuous tail capped by an elaborate baseplate ([@bib39]). Like other tailed, double-stranded (ds) DNA bacteriophages (order Caudovirales), the 80α capsid protein (CP, 324 residues) is first assembled into an empty procapsid, requiring a scaffolding protein (SP, 206 residues), which acts as a chaperone for the assembly process. The 80α procapsid is subsequently packaged with DNA by a headful mechanism using the phage-encoded terminase, consisting of a small (TerS) and a large (TerL) subunit ([@bib20]). Tails, which are assembled independently, are added to the completed, DNA-filled capsids.

SaPIs are normally stably integrated into the host genome through expression of their Stl repressors ([@bib43]). The Stl repressor detects the presence of a helper phage by interacting with a phage early lytic gene product, such as 80α Sri or the Dut dUTPase ([@bib42]; [@bib24]), leading to derepression, excision and replication of the SaPI, followed by packaging into transducing particles made by phage-encoded proteins ([Figure 1](#fig1){ref-type="fig"}). This strategy allows the SaPI to escape the phage-induced cell lysis and instead spread horizontally through the bacterial population.

![Schematic overview of SaPI1's molecular piracy of 80α.\
Only part of the 80α genome is shown for clarity, and relevant genes are labeled: *sri*, SaPI1 derepressor; *terS*, terminase small subunit; *terL*, terminase large subunit; *PP*, portal protein; *44*, minor capsid protein gp44; *SP*, scaffolding protein; *CP*, major capsid protein. First, the 80α-encoded protein Sri interacts with the SaPI1 master repressor Stl (1), causing derepression of the rightwards operon that includes the transcriptional activator *str*, the excisionase *xis* and the replicase (*pri* and *rep*). Second, the SaPI1-encoded proteins CpmA and CpmB re-direct the capsid assembly pathway to form small capsids (2). Finally, the SaPI1-encoded TerS interacts with 80α-encoded TerL to cause specific packaging of SaPI1 DNA (3). Also labeled are the SaPI1 integrase (*int*), genes encoding staphylococcal enterotoxins K (*sek*) and Q (*seq*), and the toxic shock syndrome toxin (*tst*) gene.](elife-30822-fig1){#fig1}

SaPIs interfere with the multiplication of their helpers in many ways, including the expression of a TerS subunit that specifically recognizes SaPI DNA ([Figure 1](#fig1){ref-type="fig"}), and proteins that sequester the phage-encoded TerS protein ([@bib10]; [@bib35]). Many SaPIs also cause the redirection of the helper phage assembly pathway to form capsids that are smaller than those normally formed by the phage and are therefore unable to package complete phage genomes ([@bib10]). For SaPI1, we previously demonstrated that this size redirection depended on the SaPI1-encoded proteins CpmA and CpmB ([@bib37]; [@bib15]; [@bib13]), leading to the formation of a 45 nm diameter capsid with *T* = 4 icosahedral symmetry ([@bib15]) ([Figure 1](#fig1){ref-type="fig"}). We determined the NMR structure of N-terminal domain of CpmB, a dimeric, α-helical 72-residue protein ([@bib15]) reminiscent of the scaffolding protein of bacteriophage ϕ29 ([@bib32]). Reconstructions of SaPI1 procapsids revealed protrusions on the inside of the shell that we presumed to correspond to the CpmB dimers ([@bib15]). SP and CpmB share a homologous RIIK motif near their C-termini, leading us to hypothesize that the two proteins might interact with CP in a similar fashion ([@bib15]).

Our previous reconstructions of 80α and SaPI1 capsids were generated from data collected on film with our in-house Tecnai F20 microscope, and were limited in resolution to 9--10 Å ([@bib15]; [@bib39]). This allowed a rough homology model for CP to be built; however, many regions were poorly resolved or ambiguous, and the SP was not observed in the density maps. Here, we present the icosahedrally symmetric structures of 80α and SaPI1 procapsids at near-atomic resolution, allowing the CP and part of the SP and CpmB to be accurately modeled into the density. Our structures show that CpmB affects the shell curvature around the threefold symmetry axes and binds to CP using the same interactions as the cognate SP. As a consequence, the phage is prevented from escaping the CpmB-induced capsid size redirection by mutating its CP. This study has shown, for the first time, the detailed interactions between a scaffolding protein and a capsid, and provides new insights into the assembly and size determination process for viruses and other macromolecular complexes.

Results {#s2}
=======

Structures of 80α and SaPI1 procapsids {#s2-1}
--------------------------------------

Cryo-electron microscopy (EM) images of 80α and SaPI1 procapsids were collected on an FEI Titan Krios electron microscope equipped with a DE-20 direct electron detector ([Figure 2A,B](#fig2){ref-type="fig"}). The 80α and SaPI1 procapsid structures were solved to 3.8 Å and 3.7 Å resolution (FSC~0.143~; [Figure 2C,D](#fig2){ref-type="fig"}) from 10,527 and 14,087 particle images, respectively, using icosahedral reconstruction with *jspr* ([@bib22]). The reconstructions show the expected *T* = 7 and *T* = 4 architectures of the 80α and SaPI1 procapsids, respectively, made up of hexamers and pentamers of CP subunits ([Figure 3A,B](#fig3){ref-type="fig"}). In these maps, the protein backbones could be traced through most of the density with confidence ([Figure 3---figure supplement 1A,B](#fig3s1){ref-type="fig"}). While many side chains are not fully defined at this resolution, bulky side chains could be identified sufficiently well to allow atomic models to be built for residues 26--309 of CP in both 80α and SaPI1, and for parts of SP and CpmB ([Figure 3---figure supplement 1C--F](#fig3s1){ref-type="fig"}). The models were refined in REFMAC5 and showed good correspondence with the data up to the resolution of the map([Figure 2C,D](#fig2){ref-type="fig"}; [Figure 3---figure supplement 2A,B](#fig3s2){ref-type="fig"}). Some regions in the map---mainly corresponding to the N- and C-termini of CP---had worse resolution than the rest of the structure, presumably due to structural heterogeneity or disorder ([Figure 3---figure supplement 2C,D](#fig3s2){ref-type="fig"}), and could not be modeled unambiguously. The pentamer density generally had lower resolution than the hexamers, perhaps due to unequal packing of subunits at the fivefold vertex, and averaging with the dodecameric portal that occupies one of the twelve vertices.

![Cryo-EM data.\
(**A, B**) Electron micrographs of 80α (**A**) and SaPI1 (**B**) procapsids. Scale bar, 100 nm. (**C, D**) Fourier Shell Correlation (FSC) curves between maps calculated from the two half datasets (blue) and between the model and the map (orange) for 80α (**A**) and SaPI1 (**B**). The resolution limits at 0.143 cutoff (dashed line) are indicated. The discrepancy between the model and the map for SaPI1 is likely due to the disordered and unmodeled portions of the CpmB protrusions.](elife-30822-fig2){#fig2}

![Reconstruction of 80α and SaPI1 procapsids.\
(**A, B**) Isosurface representation of the 80α (**A**) and SaPI1 (**B**) reconstructions, colored radially on an absolute scale (color bar). The triangles represent one icosahedral face, delimited by three fivefold axes. Icosahedral twofold and threefold symmetry axes are indicated by ovals and triangles, respectively. (**C, D**) Ribbon representations of the C subunits of the 80α (**C**) and SaPI1 (**D**) atomic models. N-arm, red; P domain, green; E-loop, yellow; A-domain, blue. SP (in 80α), purple; CpmB (in SaPI1), orange. Locations of α-helices α3 (the spine helix), α5 and α6, and the A-loop are also indicated in (**C**). (**D**) Isosurface representation of a 30 Å thick slice through the SaPI1 procapsid map, showing the protruding domains on the inside of the shell (arrows), colored radially on the same scale as in (**B**). (**G**) Electrostatic surface of the 80α CP subunit C, colored according to charge (blue, most positive; red, most negative).](elife-30822-fig3){#fig3}

The CP models show the expected HK97-like fold common to the Caudovirales, divided into A- and P-domains, with an extended E-loop and an N-arm that folds along the inside of the P-domain ([Figure 3C,D](#fig3){ref-type="fig"}). The long 'spine helix' (α3) in the P-domain is a characteristic feature of the HK97 fold. In 80α, this helix is kinked at residue P132 ([@bib39]). Residues 263--285 form an insertion into the P-domain called the P-loop. The P-loop and most of the E-loop were not resolved in the previous low-resolution maps ([@bib15]; [@bib39]), but could be modeled with confidence in the new maps. In addition, the C-terminal part of SP could be identified, and was modeled de novo into the density (see below). In the SaPI1 reconstruction, internal densities corresponding to the previously described CpmB dimers ([@bib15]) were clearly discernible ([Figure 3E](#fig3){ref-type="fig"}), but noisy, and only the C-terminal parts closest to the capsid were interpretable in terms of the molecular structure of the protein ([Figure 3D](#fig3){ref-type="fig"}).An electrostatic surface representation of one of the CP subunits shows a characteristic distribution of positive and negative charges on opposite sides of the A-domain ([Figure 3F](#fig3){ref-type="fig"}).

There are seven CP subunits (A--G) in the asymmetric unit in the *T* = 7 80α procapsid structure, which are organized into A~5~ pentamers and BCDEFG hexamers ([Figure 4A](#fig4){ref-type="fig"}). The seven subunits can be superimposed with overall root-mean-square deviations (RMSD) ranging from 1.0 Å to 3.3 Å, with most of the differences localized to the E-loops ([Figure 4A](#fig4){ref-type="fig"}; [Table 1](#table1){ref-type="table"}). In the *T* = 4 SaPI1 procapsid, there are four subunits, organized as A~5~ pentamers and (BCD)~2~ hexamers ([Figure 4B](#fig4){ref-type="fig"}), which superimpose with RMSD = 1.5--2.9 Å ([Figure 4B](#fig4){ref-type="fig"}; [Table 1](#table1){ref-type="table"}). These hexamers sit on the icosahedral twofold axes and thus have strict twofold symmetry. Strikingly, this twofold symmetry is retained in the 80α hexamers although no symmetry is imposed. Thus, the most similar subunits in the 80α capsid are those pairs related across this quasi-twofold symmetry axis (B--E, C--F and D--G), with RMSD values between 1.0--1.5 Å ([Table 1](#table1){ref-type="table"}). The entire hexamer and pentamer assemblies are very similar between 80α and SaPI1 ([Figure 4C,D](#fig4){ref-type="fig"}), and corresponding subunits in 80α and SaPI1 superimpose with RMSD ≤1.5 Å ([Table 1](#table1){ref-type="table"}).

![Comparison of CP subunits.\
(**A, B**) Superposition of the backbones of the seven subunits of 80α (**A**) and the four subunits of SaPI1 (**B**). Panels on the right are rotated by 90°. The two distinct conformations of the E-loop ('UP' and 'DOWN') are indicated on the 80α superposition. The subunits are colored according to the schematic diagrams on the left (A, red; B, blue; C, green; D, yellow; E, tan; F, orange; G, purple). The orange ovals in (**B**) represent the CpmB dimers. (**C, D**) Superpositions of the pentamers (**C**) and hexamers (**D**) of 80α (gray) and SaPI1 (blue), in ribbon representation.](elife-30822-fig4){#fig4}
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###### Root-mean square deviation (RMSD) values (in Å) between subunit pairs within 80α, within SaPI1 and between 80α and SaPI1.

Values for 'unpruned' structures include all atoms when determining the best fit. Values for 'pruned' structures only include the best matching residue pairs. Pruning was done in UCSF Chimera using standard parameters. For 80α, pairs of subunits related across the quasi-twofold axis are highlighted in green. Comparison of subunits for which the E-loops are in the 'UP' conformation are highlighted in blue.

  Root mean square deviation between CP subunits                                 
  ------------------------------------------------ --------- ----- ------- ----- -------
  **80α procapsid**                                                              
   subA                                            subB      215   0.986   284   2.927
   subA                                            subC      250   0.897   284   1.521
   subA                                            subD      239   0.943   284   2.902
   subA                                            subE      218   0.989   284   2.900
   subA                                            subF      252   0.899   284   1.533
   subA                                            subG      239   1.024   284   2.878
   subB                                            subC      224   0.881   284   3.072
   subB                                            subD      229   0.955   284   1.901
   subB                                            subE      251   0.727   284   1.506
   subB                                            subF      219   0.907   284   3.244
   subB                                            subG      232   0.909   284   1.686
   subC                                            subD      241   0.853   284   3.002
   subC                                            subE      225   0.923   284   3.108
   subC                                            subF      271   0.764   284   0.987
   subC                                            subG      237   0.860   284   2.974
   subD                                            subE      231   1.001   284   1.715
   subD                                            subF      246   0.781   284   3.195
   subD                                            subG      262   0.704   284   1.302
   subE                                            subF      220   0.979   284   3.257
   subE                                            subG      236   0.981   284   1.654
   subF                                            subG      242   0.847   284   3.104
  **SaPI1 procapsid**                                                            
   subA                                            subB      218   1.047   284   2.656
   subA                                            subC      247   1.092   284   1.572
   subA                                            subD      223   1.108   284   2.862
   subB                                            subC      220   1.040   284   2.865
   subB                                            subD      231   1.040   284   1.633
   subC                                            subD      242   0.921   284   2.669
  **SaPI1 vs. 80α**                                                              
  **SaPI1**                                        **80α**                       
   subA                                            subA      259   0.920   284   1.495
   subB                                            subB      250   0.926   284   1.443
   subB                                            subE      257   0.823   284   1.380
   subC                                            subC      268   0.935   284   1.165
   subC                                            subF      268   0.997   284   1.190
   subD                                            subD      247   0.948   284   1.536
   subD                                            subG      262   0.939   284   1.170

Interactions between subunits within the hexamers and pentamers are mediated primarily via the E-loops and A-domains. In the A-domains, interactions involve several charged residues in the α5 and α6 helices and in the A-loops ([Figure 5A,B](#fig5){ref-type="fig"}). The hexamers have a distinct 'skew' along a plane that separates the CDE subunits from FGB, leading to distinct differences in inter-subunit interactions in the A domains ([Figure 5A](#fig5){ref-type="fig"}). This skew is also accommodated by conformational differences in the E-loops, which segregate into two distinct classes related by a 20° rotation ([Figure 4A,B](#fig4){ref-type="fig"}). The 'up' conformation includes the two subunits whose E-loops reach across this skew plane (C and F) as well as the pentamer subunit (A), while the other subunits are in the 'down' conformation. In is unclear whether the E-loops simply conform to the skewed hexamer geometry, or themselves induce the skew in the hexamers. The E-loop forms a β-hairpin structure that contains several aromatic residues and wraps around the P-domain of the adjacent subunit, where it engages with the P-loop via a short β-sheet ([Figure 5C](#fig5){ref-type="fig"}). The contact surface between the E-loop and the adjacent subunit's P domain is extensive, covering an area of ≈1000 Å^2^ or ≈6% of the subunit surface.

![Interactions between capsid proteins.\
(**A, B**) Ribbon representation of the 80α pentamer (**A**) and hexamer (**B**), showing the detailed interactions between the A-domains. Helices α5 and α6 and the A-loop are colored according to the color scheme in [Figure 4A](#fig4){ref-type="fig"}. The skew plane between B-C and E-F subunits is indicated by the dashed line. Pertinent residues are shown in stick representation and labeled in the expanded view on the right, showing the two distinct types of A-domain interactions. (**C**) Detail of the 80α model, showing the interactions between the E-loop of subunit D (yellow) and the P-domain and P-loop of subunit C (green). (**D**) Detail of the trimer interaction at the icosahedral threefold axis showing three E subunits (tan) and the corresponding adjacent F subunits (orange). Key residues involved in the threefold interaction, as well as W98, are indicated in stick model in the expanded view.](elife-30822-fig5){#fig5}

To complete the shell assembly, the capsomers are tied together via trivalent interactions, of which there are three types in the 80α capsid (ABG, CDF and EEE; [Figure 4A](#fig4){ref-type="fig"}) and two in SaPI1 (ABD and CCC; [Figure 4B](#fig4){ref-type="fig"}). These interactions are mediated by several residues in the P-loops, which come together to form a trefoil structure that also involves residues at the tip of the E-loop of the adjacent subunit ([Figure 5D](#fig5){ref-type="fig"}). An additional contact is made by two quasi-twofold related W98 residues in the P domains that engage in parallel-displaced aromatic stacking ([Figure 5D](#fig5){ref-type="fig"}).

To define the differences between the 80α and SaPI1 shells, each capsomer was represented by a plane drawn between equivalent atoms in the constituent (five or six) subunits, and the interior, dihedral angles between planes were calculated. There are four such angles in the 80α capsid (α, β, γ and δ) and two in SaPI1 (α and β) ([Figure 6A,B](#fig6){ref-type="fig"}). These angles were consistently greater in 80α capsids compared to SaPI1 ([Figure 6C](#fig6){ref-type="fig"}). The angle that relates hexamers around the icosahedral threefold axis (α) differed more (13.1°) than that relating hexamers to pentamers (β). Such differences, propagated throughout the lattice, lead to the overall greater curvature that defines the small SaPI1 capsid ([Figure 6D](#fig6){ref-type="fig"}).

![Comparison of capsomer angles in 80α and SaPI1.\
(**A, B**) Schematic diagrams showing the organization of hexamers and pentamers in the *T* = 7 (**A**) and *T* = 4 (**B**) lattices. The dihedral angles between hexamers are defined by the Greek letters α--δ. Type 1, 2 and 3 threefold axes are indicated. (**C**) Table of the calculated interior inter-capsomeric dihedral angles in 80α and SaPI1. The Δ column indicates the difference between corresponding angles. (**D**) Ribbon representation of a slab through one half of the 80α (gray) and SaPI1 (blue) shells, showing how the difference in inter-capsomer angles are propagated through the lattice. The models were aligned at one fivefold vertex (shown at bottom of diagram) and the planes representing the capsomers (gray and blue circles) and the resulting α and β angles are shown.](elife-30822-fig6){#fig6}

Interactions between scaffolding and capsid proteins {#s2-2}
----------------------------------------------------

The 80α procapsid map had a density next to N-arm helix α1 ([Figure 7A](#fig7){ref-type="fig"}) that was identified as the 16 C-terminal residues of SP, which were built de novo as an 11-residue amphipathic α-helix followed by a 5-residue 'hook'. The lower density of this feature is indicative of low occupancy, consistent with the previously estimated CP:SP molar ratio of 2:1 ([@bib37]). The hook includes the conserved RIIK motif that was previously hypothesized to interact with CP ([@bib15]). The RIIK motif points into the hydrophobic cleft between the A and P domains, where R202, I203 and I204 make numerous contacts with the CP ([Figure 7B](#fig7){ref-type="fig"}; [Table 2](#table2){ref-type="table"}). In the preceding α-helix, L194, I197, A198 and K201 make contacts predominantly with the N-arm α-helix of CP ([Figure 7B](#fig7){ref-type="fig"}; [Table 2](#table2){ref-type="table"}). In subunits C and F only, residues Q192, R199 and N206 contact the adjacent CP subunits (B and E, respectively) ([Figure 7B](#fig7){ref-type="fig"}), presumably reflecting the hexamer skew that shifts these subunits relative to each other ([Figure 5A](#fig5){ref-type="fig"}).

![Interaction of CP with SP and CpmB.\
(**A**) Ribbon diagram of CP and SP from subunit C of the 80α procapsid with the density corresponding to SP superimposed, colored as in [Figure 3E](#fig3){ref-type="fig"}. (**B**) Detail of the SP-CP interaction, with relevant residues highlighted (stick representation) and labeled. Key interactions (\<4 Å) are indicated by stippled lines. (**C**) Ribbon diagram of CP and CpmB from subunit C in the SaPI1 procapsid showing the density corresponding to CpmB, colored as in [Figure 3F](#fig3){ref-type="fig"}. The NMR structure of the N-terminal dimerization domain of CpmB (salmon) has been placed in the density, but could not be modeled accurately. (**D**) Detail of CpmB-CP interaction with relevant residues and distances (\<4 Å) indicated. (**E**) Superposition of CpmB (blue) and SP (gray). Side chains in CpmB for residues that differ from their equivalents in SP are shown in red. (**F**) Ribbon diagram showing the interaction of one CpmB dimer (orange and salmon) with two adjacent hexameric capsomers. The **C** and **D** subunits are colored (green and yellow, respectively); other subunits are in gray. The positions of two twofold and one threefold symmetry axis are indicated.](elife-30822-fig7){#fig7}
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###### List of contacts between SP and CP in the 80α procapsid (panel A, left) and between CpmB and CP in the SaPI1 procapsid (panel B, right).

Most contacts are within the same subunit (chain C), but some contacts are made with the adjacent subunit (chain B). Corresponding residues in SP and CpmB are on the same row. The assigned SP sequence starts on P191, while CpmB starts on Q48. A contact is defined as an interatomic distance of ≤4 Å. The table lists the specific residues that are involved in these contacts and enumerates the residues (\# Res) and atoms (\# Atoms) that contribute to these contacts. Residues that make the most contacts (≥5 interatomic pairs) are highlighted in green, while those that display ≤1 contacts are highlighted in red. 'Intermediate' contacts (2--4) are shown in yellow.

  **A.** 80α procapsid. contacts (≤4 Å) between SP (subunit C) and CP   **B.** SaPI1 procapsid. contacts (≤4 Å) between CpmB (subunit C) and CP                                                                                                    
  --------------------------------------------------------------------- ------------------------------------------------------------------------- -------------------------- ------------ --- ---- ---- ---- -------------------- ------------ --- ----
                                                                                                                                                                                                                                                   
                                                                                                                                                                                                   Q    48                        N120         1   5
                                                                                                                                                                                                   E    49                                     0   0
                                                                                                                                                                                                   E    50                                     0   0
                                                                                                                                                                                                   Q    51                        E117, N120   2   13
                                                                                                                                                                                                   S    52                                     0   0
                                                                                                                                                                                                   K    53                                     0   0
                                                                                                                                                                                                   Q    54   N41                               1   2
                                                                                                                                                                                                   K    55   E67                  E117, Y121   3   7
                                                                                                                                                                                                   Q    56                        Q125         1   11
                                                                                                                                                                                                   Y    57                                     0   0
   P                                                                    191                                                                                                               0   0    G    58                                     0   0
   Q                                                                    192                                                                                                  E129, Y121   2   5    T    59                                     0   0
   N                                                                    193                                                                                                               0   0    T    60                                     0   0
   L                                                                    194                                                                       T45, L48, I253                          3   6    L    61   T45                               1   1
   A                                                                    195                                                                       Y63                                     1   1    Q    62   Y63, E64, P65                     3   17
   E                                                                    196                                                                                                               0   0    N    63                                     0   0
   I                                                                    197                                                                       T45, Q49, M52                           3   4    L    64   Q49                               1   7
   A                                                                    198                                                                       M52, Y63                                2   4    A    65   M52, Y63                          2   5
   R                                                                    199                                                                                                  E50, P32     2   5    K    66                        P132         1   2
   Q                                                                    200                                                                                                               0   0    Q    67                                     0   0
   K                                                                    201                                                                       Q49, E53                                2   6    N    68   M52, E53                          2   5
   R                                                                    202                                                                       Q59, L60, G61, K62, G247                5   4    R    69   M58, Q59, L60, G61                4   8
   I                                                                    203                                                                       Q59, V232, P230                         3   7    I    70   Q59, P230                         2   6
   I                                                                    204                                                                       L60, N194, A195, P230                   4   11   I    71   N194, P230           K235         3   3
   K                                                                    205                                                                                                               0   0    K    72                        K235         1   1
   N                                                                    206                                                                                                  Y139, K235   2   6    --   --                                         

The SaPI1 procapsid map had the internal protrusions previously attributed to dimers of CpmB ([@bib15]) ([Figure 3E](#fig3){ref-type="fig"}). The distal parts of the protrusions were not well ordered and appeared to correspond to a superposition of several alternate orientations of the CpmB N-terminal dimerization domain, for which we previously determined the NMR structure ([Figure 7C](#fig7){ref-type="fig"}). Closer to the capsid shell, the density became interpretable, and was modeled de novo as residues 41--72 of CpmB ([Figure 7D](#fig7){ref-type="fig"}). The C-terminal part of CpmB that includes the RIIK motif forms a helix-and-hook structure that is almost identical to that formed by SP in the 80α procapsid, and makes similar interactions with CP ([Figure 7D,E](#fig7){ref-type="fig"}). Contacts between CpmB and adjacent CP subunits are more extensive than in the 80α procapsid, involving several additional Gln residues in the α-helix (Q48, Q51, Q56) ([Figure 7D](#fig7){ref-type="fig"}). Each CpmB dimer straddles two capsomers with legs that connect with the capsid shell ([Figures 3E](#fig3){ref-type="fig"} and [7F](#fig7){ref-type="fig"}). There are two types of protrusions: one that ties together C and D subunits around the threefold axis, and another, weaker density, that interacts with A and B subunits, connecting hexamers and pentamers around quasi-threefold symmetry axes ([Figure 4B](#fig4){ref-type="fig"}).

Mutational analysis of the SP-CP interaction {#s2-3}
--------------------------------------------

We previously made an 80α lysogen (strain ST82; see Key Resources) with *cpmA* and *cpmB* inserted into the capsid operon immediately upstream of the SP gene (ORF46) ([@bib13]). Phage particles produced by induction of this lysogen had predominantly small capsids that were unable to package a complete 80α genome, and were thus non-infectious. We screened this lysogen for escape mutants that would evade size redirection, make infectious *T* = 7 particles, and form plaques. The escape mutants identified were exclusively located in the *cpmAB* insertion. Of the sixteen mutants analyzed, five had lost the insertion (only one of these was sequenced and it retained only 174 bp at the beginning of *cpmA*), five had nonsense mutations in *cpmB*, and six were missense mutations in *cpmB*. The nonsense mutants had lost from 8 to 45 residues from the C-terminus of CpmB, demonstrating the importance of the C-terminus for CpmB function. The CpmB missense mutations included V31D, D34N, R69K, R69S, and I70T. V31 and D34 correspond to the dimer interface observed in the NMR structure of CpmB ([@bib15]), suggesting that these mutants were defective in dimerization. R69 and I70 are part of the RIIK motif at the C-terminus of CpmB ([Figure 8](#fig8){ref-type="fig"}) and both make numerous contacts with CP in the SaPI1 procapsid structure ([Table 2](#table2){ref-type="table"}). Mutants at these sites presumably led to a failure of CpmB to interact with CP.

![Sequence alignment of the C-terminal domains of SP and CpmB.\
Size redirection negative mutations in CpmB and lethal mutations in SP are indicated (red). The mutations in CP that suppressed the I203T mutant are listed (green). Alignment generated in ClustalW and rendered with ESPript 2.0.](elife-30822-fig8){#fig8}

Based on the observed homology between the C-termini of CpmB and SP ([Figure 8](#fig8){ref-type="fig"}), we introduced the corresponding mutations (R202K and I203T) individually into the RIIK motif of SP (strains ST196 and ST358). Like the corresponding residues in CpmB, both residues form numerous contacts with CP in the 80α procapsid ([Figure 7](#fig7){ref-type="fig"}; [Table 2](#table2){ref-type="table"}). As expected, both mutations were lethal to the phage ([Table 3](#table3){ref-type="table"}). In the few plaques that formed, R202K had reverted to Arg. In order to identify second-site mutants in CP that might compensate for the SP defects, we generated R202S and R202E (strains ST278 and ST279), for which two base substitutions would be required for reversion. These mutations were also lethal ([Table 3](#table3){ref-type="table"}) and no compensatory mutations or revertants were identified. All mutations at R202 were also unable to mobilize SaPI1, demonstrating that this defect could not be compensated by wildtype CpmB (strains ST197, ST366 and ST367; [Table 3](#table3){ref-type="table"}).

10.7554/eLife.30822.014

###### Genetic analysis of 80α and SaPI1, listing the *S. aureus* strains and the genotypes of the 80α prophages and SaPI1 elements that they harbor.

SaPI1 also includes the *tst::tetM* insertion that confers tetracycline resistance. The corresponding phage titers (PFU/ml) and *tetM* transducing titers (TU/ml) are from filtered lysates resulting from induction with mitomycin C. Titers of mutations considered lethal or greatly impaired are shown in red; titers that are essentially wildtype are shown in green. WT = wildtype; N/D = not determined.

  Strain    Phage           SaPI1           Phage titer   SaPI1 titer
  --------- --------------- --------------- ------------- -------------
  RN10616   WT              --              8.70E + 10    --
  RN10628   WT              WT              5.10E + 08    1.33E + 08
                                                          
  ST196     SP R202K        --              \<10          --
  ST197     SP R202K        WT              N/D           \<10
  ST278     SP R202S        --              \<10          --
  ST366     SP R202S        WT              \<10          1.67E + 01
  ST279     SP R202E        --              \<10          --
  ST367     SP R202E        WT              N/D           \<10
  ST358     SP I203T        --              1.00E + 02    --
  ST368     SP I203T        WT              1.71E + 02    6.67E + 06
  ST469     SP I204L        --              5.33E + 10    --
  ST417     SP A198I        --              1.00E + 01    --
  ST454     SP A198I        WT              \<10          4.18E + 06
                                                          
  ST384     CP M52L         --              1.30E + 10    --
  ST415     CP M52Q         --              1.00E + 01    --
  ST481     CP M52Q         WT              \<10          3.00E + 01
  ST385     CP Y123C        --              1.47E + 10    --
                                                          
  ST466     SP::CpmB~CTD~   --              2.70E + 09    --
  ST467     SP::CpmB~CTD~   WT              9.00E + 06    9.25E + 05
  ST468     SP::CpmB~CTD~   CpmB::SP~CTD~   6.80E + 06    9.00E + 05
  ST458     WT              CpmB::SP~CTD~   1.80E + 08    9.60E + 08
  ST465     SP R202E        CpmB::SP~CTD~   \<10          1.40E + 02

For the SP I203T mutant, compensatory mutations resulting in plaque formation appeared at low frequency in both SP and CP. Pseudo-revertants of I203T included I203M, I203L and I203K, suggesting that a long, hydrophobic side chain is important at this position. I203T was also rescued by a second mutation in SP (K201I), possibly by recovering the local hydrophobicity. In the CP, compensatory mutations occurred in M52, which was repeatedly replaced by Leu and Ile, and Y123, which changed to Cys ([Figure 8](#fig8){ref-type="fig"}), suggesting an involvement of these residues in SP binding. Neither M52L nor Y123C introduced separately into 80α affected phage titers (strains ST384 and ST385; 32). In the 80α procapsid structure, M52 is located in helix α1 in the N-arm of CP and is not directly involved in interactions with SP I203T or other residues in the RIIK motif. Instead, it interacts with I197 and A198 in the SP α-helix ([Figure 7B](#fig7){ref-type="fig"}). The M52L mutation might therefore strengthen these hydrophobic interactions. Consistent with this, an M52Q mutant was lethal to the phage (ST415) and was unable to mobilize SaPI1 (ST481; [Table 3](#table3){ref-type="table"}). Mutation of A198 to Ile was also lethal to the phage, presumably because there is insufficient space for the bulky side chain (ST417; [Table 3](#table3){ref-type="table"}). The other site of compensatory mutations, Y123, is not involved in SP interactions, but instead interacts with residues in the N-arm of CP ([Figure 7B](#fig7){ref-type="fig"}), suggesting a more indirect effect on SP binding.

Surprisingly, both 80α SP mutants I203T and A198I (strains ST368 and ST454, respectively) mobilized SaPI1 with near-wildtype (RN10628) transducing titers ([Table 3](#table3){ref-type="table"}), producing capsids that were predominantly small (99% for ST368, n = 119; 97% for ST454, n = 176), although for ST368 (I203T), most of the capsids (86%) were procapsids rather than full virions ([Figure 9A,B](#fig9){ref-type="fig"}). Apparently, CpmB is able to compensate for certain lethal defects in SP, presumably by providing the required scaffolding interaction with CP. In light of this, it is perhaps surprising that SaPI1 could not compensate for mutations at R202. Presumably, the R202 defect extends beyond the scaffolding function of SP that can be compensated by CpmB. For example, R202 may be involved in portal incorporation or interaction with CpmA.

![Electron micrographs of negatively stained particles from mutant lysates.\
(**A**) Strain ST368 (80α SP I203T + wildtype SaPI1); (**B**) strain ST454 (80α SP A198I + wildtype SaPI1; (**C**) strain ST467 (80α SP-CpmB~CTD~ + wildtype SaPI1); (**D**) strain ST458 (80α wildtype + SaPI1 CpmB-SP~CTD~). Examples of small procapsids (sp), small virions (sv), and large procapsids (lp) are indicated on the images. Scale bar denotes 100 nm.](elife-30822-fig9){#fig9}

The structural and mutational data suggested that CpmB and SP bind to CP using essentially the same interactions, mediated via the C-terminal 16 residues that include the conserved RIIK motif and the preceding α-helix ([Figure 7](#fig7){ref-type="fig"}). We hypothesized that the small sequence differences between the two proteins ([Figure 8](#fig8){ref-type="fig"}) would allow CpmB to outcompete SP for binding to CP. This would allow SaPI1 to promote small capsid formation even when SP is present, as is the case during a normal SaPI1 mobilization event.

We tested this hypothesis by swapping the C-termini of SP (residues 186--206) and CpmB (residues 53--72), generating phage 80α SP-CpmB~CTD~ and SaPI1 CpmB-SP~CTD~. The strains containing the chimeric 80α and SaPI1 are listed in [Table 3](#table3){ref-type="table"}. The 80α SP-CpmB~CTD~ phage (strain ST466) had a slightly reduced phage titer compared to the wildtype phage (RN10616), and mobilized wildtype SaPI1 with a slightly reduced transducing titer (strain ST467) compared to the wildtype (RN10628; [Table 3](#table3){ref-type="table"}), showing that the C-terminal domain of CpmB functions almost as well as the native SP for interaction with CP. In the presence of SaPI1, the majority (96%, n = 24) of the capsids produced were small ([Figure 9C](#fig9){ref-type="fig"}), showing that the ability of CpmB to redirect the assembly pathway was not impaired in the presence of the chimeric SP. The same result was found when 80α SP-CpmB~CTD~ was used to mobilize the chimeric SaPI1 CpmB-SP~CTD~ (strain ST468; 100% small, n = 60). When SaPI1 CpmB-SP~CTD~ was mobilized by wildtype phage (strain ST458), the transducing titer was normal ([Table 3](#table3){ref-type="table"}). This was expected, since SaPI1 does not require a functional CpmB to transduce normally ([@bib43]). The chimeric CpmB-SP~CTD~ produced fewer small capsids (90%, n = 380) ([Figure 9D](#fig9){ref-type="fig"}) than the other chimeras, suggesting an impaired ability of the chimeric CpmB-SP~CTD~ to compete with the wildtype SP. (The difference was statistically significant (p\<0.05) compared to ST468.) The phage titer in this strain was at wildtype levels, presumably due to the presence of the wildtype SP ([Table 3](#table3){ref-type="table"}). The chimeric CpmB-SP~CTD~ was unable to compensate for the R202E defective SP (strain ST465), consistent with an additional role for this residue.

Discussion {#s3}
==========

We have solved the near-atomic resolution structures of the *S. aureus* bacteriophage 80α procapsid and the smaller procapsid produced in the presence of the SaPI1 genomic element. These structures show, for the first time, the detailed interactions between a bacteriophage scaffolding protein and the capsid, and provide unique insights into the assembly and size determination process of dsDNA bacteriophages and macromolecular complexes in general.

Internal scaffolding proteins are used by essentially all members of the Caudovirales. In some cases, the SP is part of another protein, such as the HK97-like phages, which have a functionally equivalent domain fused to their CP ([@bib11]). In bacteriophage P2 and its relatives, the SP is part of the protease ([@bib6]). An exception is the encapsulins, phage-like nanocompartments with *T* = 3 symmetry that do not undergo maturation, but remain in a procapsid state ([@bib31]). Generally, SPs are thought to curtail the inherent conformational flexibility that allows viral capsid proteins to assemble in many different ways (including aberrant capsid structures or 'crapsids') ([@bib18]; [@bib19]).

Structures of scaffolding proteins are scarce, but generally have a high α-helical content, a propensity for coiled-coil formation, and high flexibility ([@bib18]; [@bib38]). CpmB resembles the gp9 scaffolding protein of bacteriophage ϕ29, which also forms a dimeric, α-helical bundle ([@bib32]; [@bib15]). The bacteriophage P22 SP features an RKLK sequence in a helix-loop-helix motif that was genetically determined to interact with the P22 CP ([@bib12]). However, the exact interactions between these proteins and their capsids could not be resolved in the cryo-EM structures due to insufficient resolution ([@bib32]; [@bib8]).

In the 80α procapsid, the C-terminal 21 residues of SP form a 'helix-and-hook' motif that interacts extensively with the CP, especially with the N-arm ([Figure 7](#fig7){ref-type="fig"}). The rest of the SP was not resolved in the high-resolution map, suggesting that it is disordered and/or not organized with icosahedral symmetry. This is consistent with the previous low-resolution structure, which showed a diffuse core separated from the shell by a 25 Å gap ([@bib39]). Most likely, this gap is traversed by a flexible linker domain that connects this core to the helix-and-hook motif. In the absence of SP, no capsids are formed and CP levels are greatly repressed, suggesting that SP acts as a chaperone for correct folding and to prevent aggregation of CP ([@bib40]). Minor changes in the SP that disrupted CP interactions (e.g. R202K, I203T) completely abolished its function ([Table 3](#table3){ref-type="table"}).

In the SaPI1 procapsid, the SP is replaced by CpmB, which forms a helix-and-hook motif that is very similar to SP, and interacts with CP via similar interactions ([Figure 7](#fig7){ref-type="fig"}). By using the same interactions as SP, the helper phage is prevented from mutating its CP to escape the size redirection, since this would preclude SP binding as well, leading to a lethal phenotype. Consequently, no CpmB-resistant escape mutants in CP were identified in our genetic screens. If the two proteins compete directly for a binding site on CP, the effectiveness of size redirection would depend on CpmB having a higher affinity for CP than SP. Indeed, CpmB makes additional contacts with CP that were not observed with SP; however, these contacts cannot be compared directly, since the corresponding SP residues were not resolved in the 80α map. Consistent with a competition model, SaPI1 with a chimeric CpmB carrying the C-terminus of SP (CpmB-SP~CTD~) produced more large capsids than wildtype CpmB (Strain ST458; [Figure 9D](#fig9){ref-type="fig"}).

Once bound to CP, how does CpmB induce the formation of small capsids? Comparison of the 80α and SaPI1 procapsid structures shows that the hexameric capsomers are very similar, in spite of the different environments that they occupy in the two capsids ([Figure 4D](#fig4){ref-type="fig"}). The pentamers have similar environments in both capsids and were expected to be similar. Clearly, CpmB does not affect the structure of the capsomers themselves. Instead, large and small procapsids differ primarily in the way that the hexamers and pentamers interact with each other around the icosahedral and quasi-threefold axes of symmetry ([Figure 6](#fig6){ref-type="fig"}). The small capsids have a more acute dihedral angle between capsomers, especially around the icosahedral threefold axis ([Figure 6](#fig6){ref-type="fig"}), where we previously showed that CpmB dimer occupancy was higher ([@bib15]). CpmB dimers constrain these angles by straddling adjacent capsomers, whereas the longer, more flexible N-terminal domain of SP apparently does not constrain the capsomers in the same way. In a flat plane, hexamers can be incorporated *ad infinitum*, but on a curved surface, pentamers will have to be incorporated at specific points in order to close the lattice ([Figure 10](#fig10){ref-type="fig"}). It should be noted that the observed hexamer skew is also a necessary consequence of placing the hexamers on a curved surface. In the mature shell, the icosahedral faces are almost flat, and capsomers are symmetrical ([@bib39]). In the absence of CpmB, the less curved shell allows the incorporation of additional hexamers before requiring a pentamer, resulting in the *T* = 7 shell ([Figures 6](#fig6){ref-type="fig"} and [10](#fig10){ref-type="fig"}). In the presence of CpmB, the more curved trimer of hexamers would need to incorporate pentamers more frequently, resulting in the smaller, *T* = 4 shell ([Figures 6](#fig6){ref-type="fig"} and [10](#fig10){ref-type="fig"}).

![Schematic model for scaffolding competition-mediated capsid size redirection.\
In this scheme, SP is needed for the correct folding of CP (1), which is only stable as an oligomer. The E-loop conformation is 'up' or 'down' depending on its binding to a neighboring CP subunit (2). SP might be involved in this conformational switching. Subunits are assembled into hexamers (and possibly other oligomers), which are independent of the presence or absence of CpmB (3). The curvature imposed on the nascent shell by the trivalent interaction of hexamers (4) forces the incorporation of pentamers into the lattice at specific points (5), leading to a *T* = 7 shell. The presence of CpmB dimers imposes a sharper angle between hexamers (6), leading to the more frequent incorporation of pentamers and the formation of a the smaller, T = 4 shell. CpmA is thought to facilitate the removal of SP to provide access for CpmB (6).](elife-30822-fig10){#fig10}

We previously showed small capsid formation requires CpmA as well as CpmB ([@bib15]; [@bib13]; [@bib40]). The role of CpmA in the size redirection process is still unclear. Co-expression of CpmA with CP and SP in the absence of CpmB led to a failure to assemble capsids ([@bib40]), and a SaPI1 Δ*cpmB* mutant produced a large fraction of aberrant shells ([@bib15]). One possibility is that CpmA is required to remove SP from its binding site on CP and thereby provide access for CpmB ([Figure 10](#fig10){ref-type="fig"}). Perhaps CpmA is needed to disrupt an internal core that would otherwise prevent the formation of a smaller shell.

SP is required for the formation of viable transducing particles even in the presence of a complete SaPI1 element ([@bib40]), indicating that there are some functions of SP that cannot be provided by CpmB. Consequently, although CpmB could compensate for certain lethal SP mutants (I203T and A198I), it was unable to compensate for mutations at R202. SP may be required early in the assembly process to ensure the correct folding of CP, or to control the conformational switching during formation of hexamers and pentamers ([Figure 10](#fig10){ref-type="fig"}). It is also likely that SP is required for incorporation of the portal, by analogy with bacteriophage ϕ29 ([@bib21]). Although well-formed capsids can be assembled without portals, it is likely that portals are involved in the initiation of shell assembly during phage production in vivo. Some of these functions presumably reside in the N-terminal part of the protein that was not observed in the 80α procapsid map.

Restricting the size of the capsids is only one mechanism that the SaPIs use to suppress phage multiplication during molecular piracy ([@bib10]; [@bib35]). Indeed, SaPIs are perfectly viable even if they are prevented from making small capsids, and interference with phage replication is similar. Nevertheless, *cpmAB* genes are present and highly conserved between a large number of SaPIs ([@bib34]). Recently, a different mechanism of capsid size redirection that is not dependent on CpmAB was discovered in a distinct group of SaPIs that are mobilized by *cos* site phages ([@bib5]). This example of convergent evolution suggests that size redirection is an important aspect of the long-term survival and establishment of SaPIs in the bacterial population. The SaPIs, in turn, have a profound effect on the emergence of bacterial virulence and antibiotic resistance. In either case, the respective 'helper' phages are themselves helpless in the face of these molecular pirates.

Materials and methods {#s4}
=====================

Key resources {#s4-1}
-------------

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Reagent type (species)**\   **Designation**                  **Source or reference**                                        **Identifiers**           **Additional**\
  **or resource**                                                                                                                                         **information**
  ----------------------------- -------------------------------- -------------------------------------------------------------- ------------------------- ------------------------------------------------------------------------------------------------------------------------
  strain, strain background\    RN4220                           Network onantimicrobial resistance in*Staphylococcus aureus*   NARSA: NRS144             Obtained from\
  (*Staphylococcus aureus*)                                                                                                                               Richard Novick

  strain, strain\               RN10616                          PMID: 19347993                                                                           RN4220(80α);\
  background (*S. aureus*)                                                                                                                                Obtained from\
                                                                                                                                                          Richard Novick

  strain, strain\               RN10628                          PMID: 19347993                                                                           RN4220(80α) SaPI1;\
  background (*S. aureus*)                                                                                                                                Obtained from Richard Novick

  strain, strain\               ST24                             PMID: 19347993                                                                           RN4220 (80α Δ*terS*)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST65                             PMID: 21821042                                                                           RN4220 (80α Δ*orf44*)\
  background (*S. aureus*)                                                                                                                                SaPI1

  strain, strain\               ST82                             PMID: 22709958                                                                           RN4220 (80α::SaPI1*cpmAB*)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST91                             PMID: 22980502                                                                           RN4220 (80α Δ*SP*)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST100                            PMID: 21821042                                                                           RN4220 (80α) (SaPI1Δ*cpmB*)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST196                            this paper                                                                               RN4220 (80α SP::R202K)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST197                            this paper                                                                               RN4220 (80α SP::R202K)\
  background (*S. aureus*)                                                                                                                                SaPI1

  strain, strain\               ST248                            this paper                                                                               RN4220 (80α Δ*CP*)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST278                            this paper                                                                               RN4220 (80α SP::R202S)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST279                            this paper                                                                               RN4220 (80α SP::R202E)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST358                            this paper                                                                               RN4220 (80α SP::I203T)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST366                            this paper                                                                               RN4220 (80α SP::R202S)\
  background (*S. aureus*)                                                                                                                                SaPI1

  strain, strain\               ST367                            this paper                                                                               RN4220 (80α S::R202E)\
  background (*S. aureus*)                                                                                                                                SaPI1

  strain, strain\               ST368                            this paper                                                                               RN4220 (80α SP::I203T)\
  background (*S. aureus*)                                                                                                                                SaPI1

  strain, strain\               ST384                            this paper                                                                               RN4220 (80α CP::M52L)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST385                            this paper                                                                               RN4220 (80α CP::Y123C)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST415                            this paper                                                                               RN4220 (80α CP::M52Q)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST417                            this paper                                                                               RN4220 (80α SP::A198I)
  background (*S. aureus*)                                                                                                                                

  strain, strain\               ST454                            this paper                                                                               RN4220 (80α SP::A198I)\
  background (*S. aureus*)                                                                                                                                SaPI1

  strain, strain\               ST458                            this paper                                                                               RN4220 (80α) SaPI1\
  background (*S. aureus*)                                                                                                                                CpmB::SP~CTD~

  strain, strain\               ST465                            this paper                                                                               RN4220 (80α SP::R202E)\
  background (*S. aureus*)                                                                                                                                SaPI1 CpmB::SP~CTD~

  strain, strain\               ST466                            this paper                                                                               RN4220 (80α SP::CpmB~CTD~)
  background (S. aureus)                                                                                                                                  

  strain, strain\               ST467                            this paper                                                                               RN4220 (80α SP::CpmB~CTD~)\
  background (*S. aureus*)                                                                                                                                SaPI1

  strain, strain\               ST468                            this paper                                                                               RN4220 (80α SP::CpmB~CTD~)\
  background (*S. aureus*)                                                                                                                                SaPI1 CpmB::SP~CTD~

  strain, strain\               ST481                            this paper                                                                               RN4220 (80α CP::M52Q)\
  background (*S. aureus*)                                                                                                                                SaPI1

  commercial assay\             In-Fusion\                       Clontech                                                       Clontech: Cat \# 639646   <http://www.clontech.com/US/Products/Cloning_and_Competent_Cells/Cloning_Kits/Older_Cloning_Kits?sitex=10020:22372:US>
  or kit                        HD cloning kit                                                                                                            

  strain, strain\               Stellar                          Clontech                                                       Clontech: Cat \# 636763   Competent E. coli HST08\
  background\                                                                                                                                             strain
  (*Escherichia coli*)                                                                                                                                    

  recombinant DNA reagent       pMAD (plasmid)                   PMID: 15528558                                                                           Obtained from Richard\
                                                                                                                                                          Novick; used to generate all\
                                                                                                                                                          *S. aureus* strains listed above

  recombinant DNA reagent       pEW3 (plasmid)                   this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pEW14 (plasmid)                  this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pEW19 (plasmid)                  this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pEW20 (plasmid)                  this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pLAK1 (plasmid)                  this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pLKP2 (plasmid)                  this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pLKP3 (plasmid)                  this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pLKP14 (plasmid)                 this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pLKP15 (plasmid)                 this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pLKP31 (plasmid)                 this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion cloning

  recombinant DNA reagent       pLKP32 (plasmid)                 this paper                                                                               Made in pMAD by\
                                                                                                                                                          In-Fusion\
                                                                                                                                                          cloning

  software, algorithm           EMAN2\                           PMID: 16859925                                                                           Downloaded from\
                                (computer program suite)                                                                                                  [http://blake.bcm.edu/](http://blake.bcm.edu/emanwiki/EMAN2)\
                                                                                                                                                          [emanwiki/EMAN2](http://blake.bcm.edu/emanwiki/EMAN2)

  software, algorithm           jspr (computer program suite)    PMID: 24357374                                                                           Downloaded from\
                                                                                                                                                          <http://jiang.bio.purdue.edu/jspr>

  software, algorithm           BSOFT (computer program suite)   PMID:17011211                                                                            Downloaded from\
                                                                                                                                                          [https://lsbr.niams.nih.gov/bsoft/](https://lsbr.niams.nih.gov/bsoft/bsoft_download.html)\
                                                                                                                                                          [bsoft_download.html](https://lsbr.niams.nih.gov/bsoft/bsoft_download.html)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Bacterial culture {#s4-2}
-----------------

Bacterial strains used in this work are listed under key resources. *S. aureus* cultures were grown in Tryptic Soy Broth (TSB) or on Tryptic Soy Agar (TSA) plates (1.8% agarose) at 32°C. When necessary, the media were supplemented with erythromycin (5 μg/ml) or tetracycline (5 µg/ml). *Escherichia coli* strains were grown in lysogeny broth (LB) or on LB agar at 37°C and supplemented with ampicillin (100 μg/ml) when needed.

DNA manipulations {#s4-3}
-----------------

All plasmids in this study were constructed via Gibson assembly using the Clontech In-Fusion HD kit (Takara Bio USA, Mountain View, CA). Primers used are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Gel and PCR purifications were performed using the Nucleospin Gel and PCR Clean-up Kit (Macherey-Nagel, Bethlehem, PA) in accordance with the manufacturer's instructions. Plasmid DNA preparations were performed using the QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA) in accordance with the manufacturer's instructions. All plasmids were verified by Sanger sequencing (MWG Operon, Huntsville, AL).

Preparation of competent cells and transformation of *S. aureus* {#s4-4}
----------------------------------------------------------------

Electro-competent *S. aureus* cells were prepared as in [@bib27] and stored at −80°C in 60 µl aliquots. After thawing aliquots on ice, 0.3--0.6 μg plasmid DNA was added. After 30 min on ice, mixture was transferred to a 0.1 cm Gene Pulser cuvette and electroporated on the STA setting (2.50 kV for one pulse, 2.5 ms) of a MicroPulser electroporation apparatus (Bio-Rad, Hercules, CA). Immediately after the pulse, cells were transferred to a 2 ml microcentrifuge tube containing 1 ml brain heart infusion broth (BHI). Cells were recovered by shaking for 2 hr at 200 rpm, 30°C, and then plated on TSA plates supplemented with appropriate antibiotics and/or X-gal, as needed.

Allelic exchange {#s4-5}
----------------

Allelic exchange was done using the pMAD shuttle vector, as previously described ([@bib3]; [@bib37]). The desired mutations were introduced into pMAD using the Clontech In-Fusion HD cloning kit. Flanking DNA fragments containing the mutation of interest and homologous overlapping sequences were amplified via PCR ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). The purified PCR products were combined with the In-Fusion enzyme and NcoI-digested pMAD. Plasmids were then transformed into electrocompetent *S. aureus* strains with the appropriate deletions (ST91, ST100 or ST248; see Key Resources). The cells were plated on TSA with 5 µg/ml erythromycin and 200 µg/ml X-Gal at 42°C. Resultant blue colonies were selected and grown at 30°C in TSB without erythromycin, followed by plating at 42°C to cure the cells of the plasmid. White colonies were screened by PCR and sequencing to confirm the desired mutation.

Phage propagation and titering {#s4-6}
------------------------------

Lysogenic *S. aureus* strains were grown at 32°C in 25:1 CY media with β-glycerophosphate ([@bib33]). At A~600~ ≈ 0.6 OD, the cells were diluted 1:10 into a 1:1 mixture of CY + β-glycerophosphate and *S. aureus* phage buffer (50 mM Tris-HCl pH 7.8, 100 mM NaCl, 1 mM MgSO~4~ and 4 mM CaCl~2~). Lysis was induced via UV irradiation (20 s under UV in a Nuaire biological safety cabinet) or with mitomycin C (2 µg/ml), followed by shaking at 100 rpm at 32°C until lysis occurred (around 3 hr). Lysates were sterile-filtered and kept at 4°C. Serial dilutions of the lysate in *S. aureus* phage buffer were plated with 100 µl overnight culture of RN4220 on *S. aureus* phage agar ([@bib33]) using soft agar overlay supplemented with 0.5 mM CaCl~2~. All plaque assays were performed in triplicate. Plaque purification was performed with plaques cored from a plate using a sterile Pasteur pipette, resuspended in 1 ml of phage buffer, serially diluted and plated. This process was repeated twice. The final plaque was resuspended in 100 µl water and used as template for PCR amplification and for sequencing.

Transduction assays {#s4-7}
-------------------

To make double lysogens containing mutant 80α and wildtype SaPI1, 100 µl of the mutant 80α lysogen were combined 1:1 with serial dilutions of a filtered RN10628 lysate, and incubated for 15 min at 22°C. The entire volume (200 μl) was spread onto GL agar plates supplemented with 0.17 mM Na citrate and 5 μg/ml tetracycline ([@bib33]) and incubated for 48 hr at 30°C. The resulting transductants were checked by PCR and sequencing for the presence of both 80α and SaPI1. To check for mobilization of mutant and wildtype SaPI1, the double lysogens were induced with mitomycin C. The resulting lysate was filtered, combined with RN4220 and plated on GL agar with 5 µg/ml tetracycline. Resulting colonies were counted to yield a transducing titer. The values reported are the average of at least three independent determinations.

Preparation of cryo-EM samples {#s4-8}
------------------------------

80α procapsids were produced by mitomycin induction of the *S. aureus* 80α lysogen ST24 (see Key Resources), which has a deletion of the small terminase (*terS*) gene, as previously described ([@bib39]). After lysis, cell debris was removed by centrifugation at 7,000 g for 20 min. The procapsids were collected by precipitation with 10% PEG 8,000 (w/v) and 0.5 M NaCl, followed by centrifugation at 7,000 g for 20 min. The pellet was resuspended in phage buffer, made up to 1.42 g/cm^3^ CsCl, and centrifuged for 20 hr at 70,000 rpm in a Beckman NVT90 rotor at 15°C. The procapsid band was collected with a needle and dialyzed into phage dialysis buffer (25 mM Tris-HCl pH 7.8, 50 mM NaCl, 1 mM MgSO~4~ and 4 mM CaCl~2~). Separation of procapsids from phage tails was achieved by centrifugation through a 10--40% (w/v) sucrose gradient in phage dialysis buffer for 2 hr at 30,000 rpm in a Beckman SW41 rotor at 4°C. The procapsid-containing fractions were identified by SDS-PAGE, pooled and pelleted for 1 hr at 50,000 rpm in a Beckman Type 70Ti rotor at 4°C. The pellet was resuspended in phage dialysis buffer.

SaPI1 procapsids were produced similarly by induction of strain ST65, which includes SaPI1 *tst::tetM* and 80α with a deletion of *orf44*, which encodes the minor capsid protein gp44 (see Key Resources). While gp44 is essential to 80α, deletion of *orf44* has no effect on SaPI1 viability ([@bib15]). ST65 produces procapsids as well as virions, which are readily separated by CsCl density gradient centrifugation. Purification was as described for 80α procapsids. The resulting sample was contaminated with about 50% empty, expanded capsids, presumably resulting from virions that had lost their DNA. However, these capsids were easily distinguishable in the micrographs.

Electron microscopy {#s4-9}
-------------------

For negative stain EM, crude lysates were clarified by centrifugation at 5,000 g for 20 min, followed by pelleting for 1 hr at 50,000 rpm in a Beckman 70Ti rotor. The pellets were resuspended in phage dialysis buffer at approximately 0.1 mg/ml concentration. Samples were applied to glow-discharged continuous carbon grids, washed 2x with H~2~O and stained with 1% uranyl acetate before imaging in an FEI Tecnai F20 electron microscope equipped with a Gatan Ultrascan 4000 CCD camera.

Samples for cryo-EM, at a protein concentration of 1 mg/ml in phage dialysis buffer, were placed on glow-discharged (40 mA, 15 s) 200 mesh nickel Quantifoil R2/1 grids and vitrified in liquid ethane using a Vitrobot Mark IV with 5 s blot time and blot pressure of 5, at 80% humidity. Grids were checked for ice quality and concentration in an FEI Tecnai F20 microscope equipped with a Gatan 626 side entry holder, before being shipped to the Biological Science Imaging Resource (BSIR) at Florida State University in a dry cryogenic shipper. At BSIR, the grids were imaged with an FEI Titan Krios electron microscope equipped with a Direct Electron DE-20 detector operated in integrating mode, at a nominal magnification of 29,000x, resulting in 1.21 Å/pixel sampling. Data were collected at 32 frames per second and a total dose of ≈30 e^--^/Å^2^. Frames were aligned and integrated using the DE_process_frames script (v. 2.8.1) from Direct Electron, using a quanta value of 3.

Three-dimensional reconstruction and model building {#s4-10}
---------------------------------------------------

Particles were picked semi-automatically using EMAN2 ([@bib41]). Contrast transfer function parameters were determined and particle stacks were phase flipped in EMAN2. No amplitude correction was made. Icosahedral reconstruction was done using the program *jspr*, mainly following the procedures outlined in [@bib22]. The particles were divided into two half-sets at the outset, which were processed independently. Starting models for each set were generated using the random orientation generation procedure in *jspr* ([@bib22]). The final data sets included 10,527 particles for 80α and 14,087 particles for SaPI1. The final maps were generated from the re-combined half datasets and sharpened by application of an empirical inverse B factor using *bfilter* from the BSOFT suite ([@bib23]). Local resolution in both maps was calculated using ResMap ([@bib25]).

The previously generated pseudoatomic model for the 80α ([@bib39]) was used as a starting point for modeling of CP. SP was modeled de novo from the density. The 80α model was initially built in O and refined using Phenix with default parameters. The SaPI1 procapsid model was built in Coot with the 80α model as a starting point, and refined by iterative real-space refinement in Coot and by reciprocal space refinement in REFMAC5 ([@bib4]). This model was placed back into the 80α procapsid map and refined with Coot and REFMAC5. Model geometry was monitored with MolProbity ([@bib7]). To uncover any overfitting issues, the atomic coordinates of the 80α and SaPI1 models were randomly displaced by up to 0.5 Å and refined against the reconstruction from one of the two initial half sets of particles (FSCwork). These re-refined models were then compared to the reconstructions of both initial sets of particles (FSCwork and FSCtest; [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}), according to [@bib4]. UCSF Chimera was used for manipulating and aligning maps and models, calculating RMSD values, calculating and displaying molecular contacts, calculating capsomer planes, and generating figures ([@bib36]). Intercapsomeric angles were determined from calculated plane normal vectors, and model surface areas were calculated using *areaimol* in the CCP4 suite of programs ([@bib45]).

The electron density and atomic models were submitted to EMDB with accession numbers EMDB-7030, PDB ID: 6B0X for 80αand EMDB-7035, PDB ID: 6B23 for SaPI1.
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Major datasets {#s7}
--------------

The following datasets were generated:

Kizziah JLDearborn ADDokland T2017Capsid protein and C-terminal part of CpmB protein in the Staphylococcus aureus pathogenicity island 1 80alpha-derived procapsid<https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-7035>Publicly available at the EMData Bank (accession no. EMD-7035)

Kizziah JLDearborn ADDokland T2017Capsid protein and C-terminal part of scaffolding protein in the Staphylococcus aureus phage 80alpha procapsid<https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-7030>Publicly available at the EMData Bank (accession no. EMD-7030)

Kizziah JLDearborn ADDokland T2017Capsid protein and C-terminal part of scaffolding protein in the Staphylococcus aureus phage 80alpha procapsid<https://www.rcsb.org/pdb/explore/explore.do?structureId=6B0X>Publicly available at the RCSB Protein Data Bank (accession no. 6B0X)

Kizziah JLDearborn ADDokland T2017Capsid protein and C-terminal part of CpmB protein in the Staphylococcus aureus pathogenicity island 1 80alpha-derived procapsid<https://www.rcsb.org/pdb/explore/explore.do?structureId=6B23>Publicly available at the RCSB Protein Data Bank (accession no. 6B23)
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Decision letter

Egelman

Edward H

Reviewing Editor

University of Virginia

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Competing scaffolding proteins determine capsid size during mobilization of *Staphylococcus aureus* pathogenicity islands\" for consideration by *eLife*. Your article has been favorably evaluated by Gisela Storz (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The article by Dearborn et al. titled \"Competing scaffolding proteins determine capsid size during mobilization of Staphylococcus aureus pathogenicity islands\" supplies high-resolution (i.e. near atomic) cryo-EM data of T=7 and T=4 icosahedral structures and provides mechanistic insight into the role of phage 80α scaffolding protein and the SaPI protein CpmB in regulating size determination during capsid assembly. Understanding how capsids are assembled and the factors that regulate these processes has been a long-standing debate in the field. Particularly mysterious has been the fundamental question of how scaffolding proteins direct assembly of capsids into different sizes and few structures are available showing direct scaffolding protein interactions with capsids. This manuscript is nicely written and provides insightful conclusions about how scaffolding proteins (or scaffolding protein mimics like CpmB) function to control T number. Both the cryo-EM data and the mutagenesis approaches are elegant. Strikingly, the local interactions between CpmB and SP with the capsid are nearly identical, but it appears that long-range interactions are responsible for constraining capsid shell diameters.

Essential revisions:

1\) The work presented covers significant ground and is generally well supported and suitable for *eLife*. However, the basis for \"atomic modeling\" is the cryoEM density, and here the data presented include a handful of capsid images by cryoEM, surface views of the capsids, and one short segment of density demonstrating sidechain visualization ([Figure 2C](#fig2){ref-type="fig"}). The latter is troubling as of the 9 residues indicated, only 4 show convincing density in which to position the sidechains while the other 5 are outside the density. For such a key aspect of the paper on which much else depends, the phrasing \"many side chains were clearly resolved ([Figure 2C](#fig2){ref-type="fig"})\" is not apparently accurate. The 5 density-free sidechains are identified, but no other reference is made to this panel and the purpose of their labeling is unclear. Perhaps the point has been missed, or perhaps the authors can show a more convincing region of density where the quality of sidechain visualization is better revealed, either way the basis for the atomic models presented ([Figures 4B--D](#fig4){ref-type="fig"}, [Figure 6B,D and E](#fig6){ref-type="fig"}) needs to be more strongly supported. The density quality may also be demonstrated by sections, perhaps in a supplemental figure.

2\) No mention is made of structures being deposited in the EM Databank (cryoEM maps) or the PDB (models).

10.7554/eLife.30822.028

Author response

> Essential revisions:
>
> 1\) The work presented covers significant ground and is generally well supported and suitable for eLife. However, the basis for \"atomic modeling\" is the cryoEM density, and here the data presented include a handful of capsid images by cryoEM, surface views of the capsids, and one short segment of density demonstrating sidechain visualization ([Figure 2C](#fig2){ref-type="fig"}). The latter is troubling as of the 9 residues indicated, only 4 show convincing density in which to position the sidechains while the other 5 are outside the density. For such a key aspect of the paper on which much else depends, the phrasing \"many side chains were clearly resolved ([Figure 2C](#fig2){ref-type="fig"})\" is not apparently accurate. The 5 density-free sidechains are identified, but no other reference is made to this panel and the purpose of their labeling is unclear. Perhaps the point has been missed, or perhaps the authors can show a more convincing region of density where the quality of sidechain visualization is better revealed, either way the basis for the atomic models presented ([Figures 4B--D](#fig4){ref-type="fig"}, [Figure 6B,D and E](#fig6){ref-type="fig"}) needs to be more strongly supported. The density quality may also be demonstrated by sections, perhaps in a supplemental figure.

We have included a more extensive figure ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) showing the density on which the modeling was based, including one whole subunit of each structure (80a and SaPI1) and details of the density that we believe more accurately reflect the quality of the data. Obviously, at 3.8Å resolution, all side chains are not clearly resolved, and as others have reported, (negatively) charged side chains are especially prone to having poor density. Consequently, we do not expect all sidechains to be accurately modeled; however, the main chain should be correctly fitted throughout the structure, and the FSC curve between the model and the map shows that the model is accurate to the resolution of the map.

We have modified the text in the results, subsection "Structures of 80α and SaPI1 procapsids", first paragraph, to more accurately describe the quality of the map that the model was based on.

> 2\) No mention is made of structures being deposited in the EM Databank (cryoEM maps) or the PDB (models).

Submission to EMDB and PDB has now been completed, with accession numbers EMDB-7030, PDB ID 6B0X for 80a and EMDB-7035, PDB ID 6B23 for SaPI1. A statement to this effect has been added in the Materials and methods section, at the end of the subsection "Three-dimensional reconstruction and model building".
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